343 related articles for article (PubMed ID: 24486359)
1. The cost-effectiveness of influenza vaccination in elderly Australians: an exploratory analysis of the vaccine efficacy required.
Newall AT; Dehollain JP
Vaccine; 2014 Mar; 32(12):1323-5. PubMed ID: 24486359
[TBL] [Abstract][Full Text] [Related]
2. Could a federal program to promote influenza vaccination among elders be cost-effective?
Patel MS; Davis MM
Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive.
Mogasale V; Barendregt J
Aust N Z J Public Health; 2011 Apr; 35(2):180-6. PubMed ID: 21463417
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium.
Blommaert A; Bilcke J; Vandendijck Y; Hanquet G; Hens N; Beutels P
Vaccine; 2014 Oct; 32(46):6075-83. PubMed ID: 25239481
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly.
Leung MK; You JH
Vaccine; 2016 May; 34(22):2469-76. PubMed ID: 27079928
[TBL] [Abstract][Full Text] [Related]
9. Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
Thorrington D; van Leeuwen E; Ramsay M; Pebody R; Baguelin M
Vaccine; 2019 Apr; 37(15):2051-2056. PubMed ID: 30871927
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of universal influenza vaccination in a pregnant population.
Roberts S; Hollier LM; Sheffield J; Laibl V; Wendel GD
Obstet Gynecol; 2006 Jun; 107(6):1323-9. PubMed ID: 16738159
[TBL] [Abstract][Full Text] [Related]
11. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of influenza vaccination of healthy children.
Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities.
You JH; Wong WC; Ip M; Lee NL; Ho SC
J Epidemiol Community Health; 2009 Nov; 63(11):906-11. PubMed ID: 19608558
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of influenza vaccination in working-age cancer patients.
Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of an inpatient influenza immunization assessment and delivery program for children with asthma.
Teufel RJ; Basco WT; Simpson KN
J Hosp Med; 2008 Mar; 3(2):134-41. PubMed ID: 18438789
[TBL] [Abstract][Full Text] [Related]
17. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.
Aballéa S; De Juanes JR; Barbieri M; Martin M; Chancellor J; Oyagüez I; Verwee B; Largeron N
Vaccine; 2007 Sep; 25(39-40):6900-10. PubMed ID: 17764790
[TBL] [Abstract][Full Text] [Related]
18. [An economic evaluation of strategy for expanding influenza vaccination in Japan].
Hara Y
Nihon Rinsho; 2003 Nov; 61(11):2013-8. PubMed ID: 14619447
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
Navas E; Salleras L; Domínguez A; Ibáñez D; Prat A; Sentís J; Garrido P
Vaccine; 2007 Apr; 25(16):3233-9. PubMed ID: 17324489
[TBL] [Abstract][Full Text] [Related]
20. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
Brydak L; Roiz J; Faivre P; Reygrobellet C
Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
